Alerts will be sent to your verified email
Verify Email
SHELTER
|
Shelter Pharma
|
Medistep Healthcare
|
Bacil Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.08 % | 24.77 % | -73.86 % |
|
5yr Avg Net Profit Margin
|
7.29 % | 8.79 % | 0.0 |
|
Price to Book
|
0.0 | 2.91 | 1.97 |
|
P/E
|
7.19 | 11.88 | 45.46 |
|
5yr Avg Cash Conversion Cycle
|
151.86 Days | 115.71 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
71.95 | 96.98 | -950.16 |
|
5yr Avg ROCE
|
21.3 % | 33.38 % | -81.01 % |
|
5yr Avg Operating Profit Margin
|
11.0 % | 11.92 % | 0.0 |
|
5 yr average Debt to Equity
|
0.04 | 0.04 | 0.08 |
|
5yr CAGR Net Profit
|
138.7 % | 35.1 % | -28.45 % |
|
5yr Average Return on Assets
|
11.22 % | 18.77 % | -72.13 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.32 % | n/a | 0.2 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.57 % | n/a | -42.47 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
Shelter Pharma
|
Medistep Healthcare
|
Bacil Pharma
|
|---|